Arbro Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Na, Delhi, India, established in 1985.
1985 Na, Delhi, India Active
Last Updated:
About Arbro Pharmaceuticals Private Limited

Arbro Pharmaceuticals Private Limited, a active private limited company, was established on 28 June 1985 in Na, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232DL1985PTC021362. Registered under ROC Roc Delhi Ii. it is unlisted. It has an authorized capital of ₹1.99 Cr and a paid-up capital of ₹1.78 Cr.

Formerly known as Arbro Pharmaceuticals Ltd.. It upholds a compliant status. Employing 369 professional, Its leadership includes Sunil Kumar Jaitly (Whole-Time Director), Saurabh Arora (Director), Vijay Kumar Arora (Managing Director). Past directors included Promila Arora, Sunil Kumar Jaitly, Ram Avtar Singh. It holds ₹18.90 Cr open charges and ₹13.70 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 6/14,Kirti Nagar Industrialarea,New Delhi, Na, Delhi.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232DL1985PTC021362

  • Registration Number

    021362

  • Incorporation Date

    28 June 1985

  • Authorized Capital

    ₹1.99 Cr

  • Paid-Up Capital

    ₹1.78 Cr

  • ROC Code

    Roc Delhi Ii

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.99 Cr
  • Paid Up Capital ₹ 1.78 Cr
  • Company Age 40 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 18.90 Cr
  • Satisfied Charges ₹ 13.70 Cr
  • Revenue Growth **** 86.43%
  • Profit Growth **** -5.76%
  • Ebitda **** -11.91%
  • Net Worth 5.83%
  • Total Assets **** 6.50%
Company report

Arbro Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Arbro Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Arbro Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Sunil Kumar Jaitly Whole-Time Director 05 Dec 1998 Current
Saurabh Arora Director 05 Aug 2005 Current
Vijay Kumar Arora Managing Director 28 Jun 1985 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 01 Nov 2016 Past
Pramod Abcsdd Director 01 Aug 2009 Past
Pramod Abcsdd Director 01 Aug 2009 Past
Pramod Abcsdd Director 31 May 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Arbro Pharmaceuticals.

Arbro Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 86.43% increase. The company also saw a slight decrease in profitability, with a 5.76% decrease in profit. The company's net worth moved up by a moderate rise of 5.83%.

Arbro Pharmaceuticals revenue growth over time
Arbro Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
86.43%
*******
*******
*******
*******
Revenue from Operations
*******
86.36%
*******
*******
*******
*******
Total Assets
*******
6.50%
*******
*******
*******
*******
Profit or Loss
*******
-5.76%
*******
*******
*******
*******
Net Worth
*******
5.83%
*******
*******
*******
*******
EBITDA
*******
-11.91%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Arbro Pharmaceuticals?

In 2023, Arbro Pharmaceuticals had a promoter holding of 99.99% and a public holding of 0.01%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹189,025,059.00

Satisfied Charges

₹137,048,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 18.48 Cr
  • Department Of Biotechnology : 0.32 Cr
  • Others : 0.07 Cr
  • Icici Bank Limited : 0.04 Cr
Latest Charge Details
Date Lender Amount Status
08 Jul 2025 Hdfc Bank Limited ₹0.80 M Open
08 Mar 2021 Hdfc Bank Limited ₹1.79 M Open
28 Aug 2020 Hdfc Bank Limited ₹0.52 M Open
28 Aug 2018 Hdfc Bank Limited ₹0.41 M Open
28 Aug 2018 Hdfc Bank Limited ₹0.43 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Arbro Pharmaceuticals?

Arbro Pharmaceuticals has a workforce of 369 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Arbro Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arbro Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Arbro Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Arbro Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 0.08 Cr with Charge ID 101149781 was registered on 08 Jul 2025. was completed.

  • Balance Sheet

    Progress on Arbro Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii. was documented.

  • Charges

    The activity A charge with Hdfc Bank Limited of Rs. 18.03 Cr registered on 23 May 2017 with Charge ID 100104599 was modified on 09 Jul 2024. was completed.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.18 Cr with Charge ID 100440973 was registered on 08 Mar 2021. was recorded as a recent event.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.05 Cr with Charge ID 100388037 was registered on 28 Aug 2020. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Arbro Pharmaceuticals Private Limited?

The CIN of Arbro Pharmaceuticals Private Limited is U24232DL1985PTC021362.

Where is Arbro Pharmaceuticals Private Limited headquartered?

Arbro Pharmaceuticals Private Limited is headquartered at 6/14,Kirti Nagar Industrialarea,New Delhi, Na, Delhi.

When was Arbro Pharmaceuticals Private Limited incorporated?

Arbro Pharmaceuticals Private Limited was incorporated on 28 June 1985.

Who are the current directors of Arbro Pharmaceuticals Private Limited?

The current directors of Arbro Pharmaceuticals Private Limited are

What is the primary industry of Arbro Pharmaceuticals Private Limited?

The primary industry of Arbro Pharmaceuticals Private Limited is Manufacturing.

Is Arbro Pharmaceuticals Private Limited a listed company?

Arbro Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Arbro Pharmaceuticals Private Limited?

The authorized capital of Arbro Pharmaceuticals Private Limited is ₹1.99 Cr, and the paid-up capital is ₹1.78 Cr.

What is the compliance status of Arbro Pharmaceuticals Private Limited?

The compliance status of Arbro Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available